XML 61 R6.htm IDEA: XBRL DOCUMENT v3.19.3
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
Common Stock
Treasury Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Total
Beginning balance, shares at Dec. 31, 2017 54,962,535          
Beginning balance, value at Dec. 31, 2017 $ 550   $ 36,848,041 $ (32,596,374) $ 8,454 $ 4,260,671
Exercise of options, shares 1,089,144          
Exercise of options, value $ 11   264,346     264,357
Agent growth incentive stock compensation expense, shares 61,598          
Agent growth incentive stock compensation expense, value     8,279,108     8,279,108
Stock option expense     1,301,702     1,301,702
Agent equity program, shares 208,324          
Agent equity program, value $ 2   2,370,002     2,370,004
Foreign currency translation gain (loss)         (1,275) (1,275)
Net loss       (10,696,345)   (10,696,345)
Ending balance, shares at Mar. 31, 2018 56,321,601          
Ending balance, value at Mar. 31, 2018 $ 563   49,063,199 (43,292,719) 7,179 5,778,222
Beginning balance, shares at Dec. 31, 2017 54,962,535          
Beginning balance, value at Dec. 31, 2017 $ 550   36,848,041 (32,596,374) 8,454 4,260,671
Foreign currency translation gain (loss)           (2,201)
Net loss           (17,211,174)
Ending balance, shares at Sep. 30, 2018 58,968,762          
Ending balance, value at Sep. 30, 2018 $ 589   79,195,251 (55,557,542) 6,253 23,644,551
Beginning balance, shares at Dec. 31, 2017 54,962,535          
Beginning balance, value at Dec. 31, 2017 $ 550   36,848,041 (32,596,374) 8,454 4,260,671
Ending balance, shares at Dec. 31, 2018 60,609,102          
Ending balance, value at Dec. 31, 2018 $ 606   90,755,616 (60,765,266) (11,327) 29,979,629
Beginning balance, shares at Mar. 31, 2018 56,321,601          
Beginning balance, value at Mar. 31, 2018 $ 563   49,063,199 (43,292,719) 7,179 5,778,222
Exercise of options, shares 710,447          
Exercise of options, value $ 7   608,895     608,902
Agent growth incentive stock compensation expense, shares 69,401          
Agent growth incentive stock compensation expense, value $ 1   3,989,602     3,989,603
Stock option expense     1,181,969     1,181,969
Agent equity program, shares 373,573          
Agent equity program, value $ 4   5,277,342     5,277,346
Foreign currency translation gain (loss)         9,795 9,795
Net loss       (1,886,658)   (1,886,658)
Ending balance, shares at Jun. 30, 2018 57,475,022          
Ending balance, value at Jun. 30, 2018 $ 575   60,121,007 (45,179,377) 16,974 14,959,179
Other     18,011 (11,458)   6,553
Exercise of options, shares 474,696          
Exercise of options, value $ 5   876,632     876,637
Agent growth incentive stock compensation expense, shares 611,843          
Agent growth incentive stock compensation expense, value $ 5   4,238,662     4,238,667
Stock option expense     1,103,055     1,103,055
Agent equity program, shares 407,201          
Agent equity program, value $ 4   7,099,348     7,099,352
Foreign currency translation gain (loss)         (10,721) (10,721)
Net loss       (4,628,171)   (4,628,171)
Ending balance, shares at Sep. 30, 2018 58,968,762          
Ending balance, value at Sep. 30, 2018 $ 589   79,195,251 (55,557,542) 6,253 23,644,551
Cumulative effect of new accounting principle in period of adoption | Accounting Standards Update 2018-07 [Member]     5,738,536 (5,738,536)    
Beginning balance, shares at Dec. 31, 2018 60,609,102          
Beginning balance, value at Dec. 31, 2018 $ 606   90,755,616 (60,765,266) (11,327) 29,979,629
Exercise of options, shares 134,260          
Exercise of options, value $ 1   215,725     215,726
Agent growth incentive stock compensation expense, shares 136,194          
Agent growth incentive stock compensation expense, value $ 1   3,669,320     3,669,321
Stock option expense     1,215,448     1,215,448
Agent equity program, shares 620,287          
Agent equity program, value $ 4   6,210,289     6,210,293
Foreign currency translation gain (loss)         14,860 14,860
Repurchase of common stock, shares   357,752        
Repurchase of common stock, value   $ (3,647,076)       (3,647,076)
Net loss       (6,295,823)   (6,295,823)
Ending balance, shares at Mar. 31, 2019 61,499,843 357,752        
Ending balance, value at Mar. 31, 2019 $ 612 $ (3,647,076) 102,066,398 (67,061,089) 3,533 31,362,378
Beginning balance, shares at Dec. 31, 2018 60,609,102          
Beginning balance, value at Dec. 31, 2018 $ 606   90,755,616 (60,765,266) (11,327) 29,979,629
Foreign currency translation gain (loss)           $ 139,534
Repurchase of common stock, shares           1,785,945
Repurchase of common stock, value           $ (17,649,014)
Net loss           (10,338,927)
Ending balance, shares at Sep. 30, 2019 66,476,020 1,785,945        
Ending balance, value at Sep. 30, 2019 $ 665 $ (17,649,014) 133,827,909 (71,104,193) 128,207 45,203,574
Beginning balance, shares at Mar. 31, 2019 61,499,843 357,752        
Beginning balance, value at Mar. 31, 2019 $ 612 $ (3,647,076) 102,066,398 (67,061,089) 3,533 31,362,378
Exercise of options, shares 536,613          
Exercise of options, value $ 5   690,262     690,267
Agent growth incentive stock compensation expense, shares 149,008          
Agent growth incentive stock compensation expense, value $ 2   3,587,463     3,587,465
Stock option expense     1,830,508     1,830,508
Agent equity program, shares 935,177          
Agent equity program, value $ 12   10,233,901     10,233,913
Foreign currency translation gain (loss)         47,812 47,812
Repurchase of common stock, shares   460,093        
Repurchase of common stock, value   $ (4,897,976)       (4,897,976)
Net loss       (2,195,741)   (2,195,741)
Ending balance, shares at Jun. 30, 2019 63,120,641 817,845        
Ending balance, value at Jun. 30, 2019 $ 631 $ (8,545,052) 118,408,532 (69,256,830) 51,345 40,658,626
Exercise of options, shares 1,224,756          
Exercise of options, value $ 12   646,152     646,164
Agent growth incentive stock compensation expense, shares 878,083          
Agent growth incentive stock compensation expense, value $ 9   2,602,692     2,602,701
Stock option expense     1,060,175     1,060,175
Agent equity program, shares 1,252,540          
Agent equity program, value $ 13   11,110,358     11,110,371
Foreign currency translation gain (loss)         76,862 76,862
Repurchase of common stock, shares   968,100        
Repurchase of common stock, value   $ (9,103,962)       (9,103,962)
Net loss       (1,847,363)   (1,847,363)
Ending balance, shares at Sep. 30, 2019 66,476,020 1,785,945        
Ending balance, value at Sep. 30, 2019 $ 665 $ (17,649,014) $ 133,827,909 $ (71,104,193) $ 128,207 $ 45,203,574